Takeda Pharmaceutical Co. Ltd.

Pharmaceuticals
Japan
Executive 1Yasuchika Hasegawa, Chairman; Chief Executive Officer | Chairman; Chief Executive Officer
Executive 2Christophe Weber, President; Chief Operating Officer | Senior Vice President;
Earnings Per Share Growth (%)-237.36%
Cost of Goods Sold (US$ Millions)$4,367
Current Liabilities (US$ Millions)$8,473
Total Assets (US$ Millions)$12,740
Long Term Debt (Millions)$5,275
Return on Equity-5.79%
Revenue (US$ Millions)$15,524
Total Company Assets$36,008
Revenue Growth (%)8.38%
Net Income (US$ Millions)($1,199)
Earnings Per Share (US$)($1.55)
Total Equity (US$ Millions)$17,911
Profit Margin (%)-7.72%
Debt To Equity Ratio (%)0.29%
Inventories (Millions)$2,199